May increases the risk of symptomatic bradycardia
Amiodarone is an antiarrhythmic drug and Ledipasvir/Sofosbuvir is antiviral drugs, to treat chronic hepatitis-C infection. Alert: The USFDA alerts that serious risk of symptomatic bradycardia can occur when Amiodarone is taken together with Ledipasvir/Sofosbuvir combination or with Sofosbuvir alone for the treatment of hepatitis C infection. Hence, KSPC-DIRC alerts the healthcare professionals to be cautious while prescribing Amiodarone and Ledipasvir/Sofosbuvir.
This drug is available in India.